August 7th 2024
Why is it important for organizations to set long-term goals when planning for a sustainable future?
July 24th 2024
A deep dive into why this therapy has demonstrated effectiveness in various areas, including for tumors.
July 17th 2024
How teamwork among safety-net healthcare providers and pharma can make the difference.
June 7th 2024
Causal mediation analysis sought to determine how public hesitancy plays a role in the government procurement of certain vaccines.
May 30th 2024
These advancements continue to act as a key driver in helping to boost the security, efficiency, and innovation of global industries, include pharma.
Outsourced facilities management saves precious financial resources
Life sciences companies - including mid-market ones - are finding value in an outsourced service
How about a US Chamber of Healthcare Commerce?
The full range of healthcare manufacturers should have a unified voice
test
The downside of pricing specialty pharmaceuticals too high
Why 'recall readiness' should be top-of-mind for every pharma exec
Should personalized medicine imply compromised patient safety?
Continuing problems with compounding pharmacies muddle biopharma’s future direction
Why community oncology matters
Oncology is the market for today's pipeline products. Here's why the community setting needs to be preserved as a primary site of care to administer those products
Managing the specialty pharmacy channel's evolution
Focusing pharma marketing on 'headroom'
In the race to improve product performance, not enough attention is paid to 'who's actually going to switch?'
The war on prescription drug abuse
Like the other war on drugs, there's no end in sight
Pharma's stake in comparative effectiveness research
When drugs in development today hit the marketplace in 2020, they will need evidence of economic and clinical value results to be commercially successful
Liberating time in the Economy of Attention
Pharmaceutical marketing is now operating in a new landscape--the Economy of Attention
Tomorrow's biopharma industry: new biotech products or higher operational efficiency--or both?
Abbott's spinout of AbbVie offers lessons
Another go at medication adherence
A managed services approach to sales and marketing
Applying the managed services model to commercial operations can result in dramatic savings as pharma companies globalize
BeSafeRx: FDA helping consumers avoid risks of online prescription drug purchases
Complex supply chains demand a holistic approach to protect patients
The USP standard, currently in draft form, is an effort to provide recommendations for end-to-end supply chain integrity
In the evolving world of pharma compliance, The PDMA Sharing Conference provides answers
Tectonic shifts in the product-security debate
Industry is not waiting for action in Washington
The clear and present danger of counterfeit drugs
Prospects for international policing of counterfeit drugs is dim
Packaging, serialization and medication adherence: the coming connection
Modernized packaging technologies can change the drug-distribution dynamic - and improve overall healthcare
Innovative collaboration could address today's drug shortages productively
Supply chains for a patient-centric world
Tomorrow's healthcare market, driven by consumer choice and outcomes-driven economics, will create new supply chain models
FTC Approves Express Scripts/Medco Merger: Excerpts
Merger is not expected to affect specialty-distribution agreements negatively
Jobs and biopharma
Ten-year BLS projection sees a healthy industry ahead
Drug Wholesalers and the Generic Price War
Biosimilars take a big step toward the marketplace
FDA's draft documents on biosimilar regulation move the prospect one step closer
Supply chain issues for 2012
Tompkins International's annual preview of key pharma supply chain issues
Cancer care in the US -- looking back, looking forward
Begin thinking of your business as a 'disease' company vs. a 'drug' company
Industry collaborates on logistics and supply chain security
With Rx-360 already at critical mass and delivering results, the call is out for more participation